{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:25:23Z","timestamp":1791905123759,"version":"4.3.4"},"reference-count":115,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.tim.2022.01.007","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T23:06:32Z","timestamp":1644102392000},"page":"778-792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Microbiota regulation of viral infections through interferon signaling"],"prefix":"10.1016","volume":"30","author":[{"given":"Nurul I.","family":"Wirusanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan T.","family":"Baldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2022.01.007_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tim.2022.01.007_bb0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.tim.2022.01.007_bb0015","first-page":"1","article-title":"The commensal microbiota and viral infection: A comprehensive review","volume":"10","author":"Li","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad5872","article-title":"Transkingdom control of viral infection and immunity in the mammalian intestine","volume":"351","author":"Pfeiffer","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tim.2022.01.007_bb0025","first-page":"1","article-title":"Intestinal microbiota \u2013 a promising target for antiviral therapy?","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tim.2022.01.007_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-019-0182-z","article-title":"Interferon-\u03bb orchestrates innate and adaptive mucosal immune responses","volume":"19","author":"Ye","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0045","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cell.2020.10.047","article-title":"Commensal microbiota modulation of natural resistance to virus infection","volume":"183","author":"Stefan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tim.2022.01.007_bb0050","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.cell.2020.04.022","article-title":"Microbiota-Induced type I interferons instruct a poised basal state of dendritic cells","volume":"181","author":"Schaupp","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tim.2022.01.007_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.celrep.2019.05.105","article-title":"Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection","volume":"28","author":"Bradley","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.tim.2022.01.007_bb0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.1258025","article-title":"Commensal microbes and interferon-\u03bb determine persistence of enteric murine norovirus infection","volume":"347","author":"Baldridge","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tim.2022.01.007_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41564-019-0602-7","article-title":"The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type III interferon","volume":"5","author":"Grau","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tim.2022.01.007_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cell.2020.06.029","article-title":"The intestinal microbiome restricts alphavirus infection and dissemination through a bile acid-type I IFN signaling axis","volume":"182","author":"Winkler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tim.2022.01.007_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00366-21","article-title":"The intestinal microbiome primes host innate immunity against enteric virus systemic infection through type I interferon","volume":"12","author":"Yang","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.tim.2022.01.007_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00326-20","article-title":"Butyrate reprograms expression of specific interferon-stimulated genes","volume":"94","author":"Chemudupati","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2022.01.007_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11152-6","article-title":"Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response","volume":"10","author":"Antunes","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2022.01.007_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.immuni.2012.05.020","article-title":"Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota","volume":"37","author":"Ganal","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2022.01.007_bb0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","article-title":"Commensal bacteria calibrate the activation threshold of innate antiviral immunity","volume":"37","author":"Abt","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2022.01.007_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20061445","article-title":"Differential regulation of type I and type III interferon signaling","volume":"20","author":"Stanifer","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tim.2022.01.007_bb0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2022.01.007_bb0110","first-page":"1","article-title":"Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion","volume":"217","author":"Broggi","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2022.01.007_bb0115","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v10010046","article-title":"Distinct effects of type I and III interferons on enteric viruses","volume":"10","author":"Ingle","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.tim.2022.01.007_bb0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: A complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0130","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1074\/jbc.R117.777102","article-title":"Contribution of type III interferons to antiviral immunity: location, location, location","volume":"292","author":"Kotenko","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tim.2022.01.007_bb0135","article-title":"Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance","volume":"14","author":"Id","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2022.01.007_bb0140","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.it.2021.09.003","article-title":"Differential roles of interferons in innate responses to mucosal viral infections","volume":"42","author":"Walker","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058465","article-title":"Differential Activity of Type I interferon subtypes for dendritic cell differentiation","volume":"8","author":"Garcin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2022.01.007_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri3806","article-title":"Regulation of antiviral T cell responses by type I interferons","volume":"15","author":"Crouse","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0155","article-title":"Type I interferons promote germinal centers through B cell intrinsic signaling and dendritic cell dependent Th1 and Tfh cell lineages","author":"Dahlgren","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.tim.2022.01.007_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108211","article-title":"Interferon-lambda enhances the differentiation of naive B cells into plasmablasts via the mTORC1 pathway","volume":"33","author":"Syedbasha","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tim.2022.01.007_bb0165","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41590-019-0408-z","article-title":"Interferon-\u03bb modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus","volume":"20","author":"Hemann","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0170","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41590-019-0345-x","article-title":"Interferon-\u03bb enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin","volume":"20","author":"Ye","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/v10030122","article-title":"Together forever: bacterial\u2013viral interactions in infection and immunity","volume":"10","author":"Shi","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.tim.2022.01.007_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.tim.2022.01.007_bb0185","article-title":"A homeostatic interferon-lambda response to bacterial microbiota stimulates preemptive antiviral defense within discrete pockets of intestinal epithelium","author":"Van Winkle","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.tim.2022.01.007_bb0190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mi.2015.126","article-title":"Control of local immunity by airway epithelial cells","volume":"9","author":"Weitnauer","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0195","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3389\/fimmu.2018.01270","article-title":"Cytokine tuning of intestinal epithelial function","volume":"9","author":"Andrews","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0200","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.tim.2021.01.007","article-title":"Impact of type I interferons on susceptibility to bacterial pathogens","volume":"29","author":"Peignier","year":"2021","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tim.2022.01.007_bb0205","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.chom.2016.05.016","article-title":"The roles of type I interferon in bacterial infection","volume":"19","author":"Boxx","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2022.01.007_bb0210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fimmu.2012.00154","article-title":"Effects of differences in lipid A structure on TLR4 pro-inflammatory signaling and inflammasome activation","volume":"3","author":"Chilton","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0215","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cell.2016.04.007","article-title":"Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans","volume":"165","author":"Vatanen","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tim.2022.01.007_bb0220","first-page":"1","article-title":"Prophylactic efficacy of orally administered Bacillus poly-\u03b3-glutamic acid, a non-LPS TLR4 ligand, against norovirus infection in mice","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2022.01.007_bb0225","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.immuni.2013.02.024","article-title":"Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-\u03b2","volume":"38","author":"Kawashima","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2022.01.007_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1348-0421.12669","article-title":"Cytosolic DNA-sensing immune response and viral infection","volume":"63","author":"Abe","year":"2019","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0235","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/19490976.2019.1707015","article-title":"Beneficial bacteria activate type-I interferon production via the intracellular cytosolic sensors STING and MAVS","volume":"11","author":"Gutierrez-Merino","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.tim.2022.01.007_bb0240","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.4049\/jimmunol.1700250","article-title":"Type III IFNs are commonly induced by bacteria-sensing tlrs and reinforce epithelial barriers during infection","volume":"199","author":"Odendall","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tim.2022.01.007_bb0250","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0255","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1007\/s00018-019-03190-6","article-title":"Bridging intestinal immunity and gut microbiota by metabolites","volume":"76","author":"Wang","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tim.2022.01.007_bb0260","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.aam5336","article-title":"The microbial metabolite desaminotyrosine protects from influenza through type I interferon","volume":"357","author":"Steed","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.tim.2022.01.007_bb0265","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","article-title":"Microbial regulation of host physiology by short-chain fatty acids","volume":"29","author":"Van Der Hee","year":"2021","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tim.2022.01.007_bb0270","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41423-020-00625-0","article-title":"Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids","volume":"18","author":"Kim","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103293","article-title":"Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?","volume":"66","author":"Deleu","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tim.2022.01.007_bb0280","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tim.2022.01.007_bb0285","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0290","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1073\/pnas.0401126101","article-title":"Bile acids are essential for porcine enteric calicivirus replication in association with down-regulation of signal transducer and activator of transcription 1","volume":"101","author":"Chang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2022.01.007_bb0295","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1128\/JVI.00795-07","article-title":"Bile acids promote the expression of hepatitis C virus in replicon-harboring cells","volume":"81","author":"Chang","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2022.01.007_bb0300","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3389\/fimmu.2018.02289","article-title":"Metabolite-sensing G protein coupled receptor TGR5 protects host from viral infection through amplifying type I interferon responses","volume":"9","author":"Xiong","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0305","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41422-018-0136-1","article-title":"Virus-induced accumulation of intracellular bile acids activates the TGR5-\u03b2-arrestin-SRC axis to enable innate antiviral immunity","volume":"29","author":"Hu","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.tim.2022.01.007_bb0310","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000456168","article-title":"Farnesoid X receptor in mice prevents severe liver immunopathology during lymphocytic choriomeningitis virus infection","volume":"41","author":"Honke","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tim.2022.01.007_bb0315","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.coviro.2021.05.006","article-title":"The influence of microbiota-derived metabolites on viral infections","volume":"49","author":"Alwin","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.tim.2022.01.007_bb0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/bs.pmbts.2020.04.005","article-title":"Microbiota in viral infection and disease in humans and farm animals","volume":"171","author":"Yuan","year":"2020","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.tim.2022.01.007_bb0325","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chom.2020.06.014","article-title":"The impact of the microbiome on immunity to vaccination in humans","volume":"28","author":"de Jong","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2022.01.007_bb0330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41577-021-00554-7","article-title":"Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms","volume":"22","author":"Lynn","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0335","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41564-021-00969-x","article-title":"Lung microbiota and COVID-19 severity","volume":"6","author":"Dickson","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tim.2022.01.007_bb0340","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/s41564-021-00961-5","article-title":"Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome","volume":"6","author":"Sulaiman","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tim.2022.01.007_bb0345","article-title":"Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2022.01.007_bb0350","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.3389\/fimmu.2021.733364","article-title":"Interferon and hepatitis B: current and future perspectives","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0355","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jhep.2014.07.022","article-title":"A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection","volume":"61","author":"Muir","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tim.2022.01.007_bb0360","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fimmu.2017.00621","article-title":"Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients","volume":"8","author":"Phillips","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0365","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/vim.2017.0033","article-title":"Optimized DNA vaccine enhanced by adjuvant IL28B induces protective immune responses against herpes simplex virus type 2 in mice","volume":"30","author":"Zhou","year":"2017","journal-title":"Viral. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0370","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1182\/blood-2008-11-190520","article-title":"Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity","volume":"113","author":"Morrow","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tim.2022.01.007_bb0375","article-title":"Distinct roles of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infections","volume":"12","author":"Da Lin","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2022.01.007_bb0380","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm.3950","article-title":"Early life dynamics of the human gut virome and bacterial microbiome in infants","volume":"21","author":"Lim","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.tim.2022.01.007_bb0385","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tim.2022.01.007_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-019-1616-2","article-title":"Aging progression of human gut microbiota","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.tim.2022.01.007_bb0395","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1126\/science.1257147","article-title":"Enteric bacteria promote human and mouse norovirus infection of B cells","volume":"346","author":"Jones","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tim.2022.01.007_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chom.2021.12.002","article-title":"Enteric virome negatively affects seroconversion following oral rotavirus vaccination in a longitudinally sampled cohort of Ghanaian infants","volume":"30","author":"Kim","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2022.01.007_bb0405","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.chom.2021.03.015","article-title":"Enteric viruses evoke broad host immune responses resembling those elicited by the bacterial microbiome","volume":"29","author":"Dallari","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2022.01.007_bb0410","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.03.009","article-title":"Enteric viruses ameliorate gut inflammation via Toll-like receptor 3 and Toll-like receptor 7-mediated interferon-\u03b2 production","volume":"44","author":"Yang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2022.01.007_bb0415","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature13960","article-title":"An enteric virus can replace the beneficial function of commensal bacteria","volume":"516","author":"Kernbauer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tim.2022.01.007_bb0420","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41564-019-0416-7","article-title":"Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-\u03bb","volume":"4","author":"Ingle","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tim.2022.01.007_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9691","article-title":"Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection","volume":"363","author":"Sweere","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tim.2022.01.007_bb0430","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.chom.2017.10.013","article-title":"Commensal fungi recapitulate the protective benefits of intestinal bacteria","volume":"22","author":"Jiang","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2022.01.007_bb0435","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.abd0919","article-title":"Debaryomyces is enriched in Crohn\u2019s disease intestinal tissue and impairs healing in mice","volume":"371","author":"Jain","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.tim.2022.01.007_bb0440","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41385-018-0008-5","article-title":"The impact of a helminth-modified microbiome on host immunity","volume":"11","author":"Brosschot","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0445","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaci.2017.01.016","article-title":"Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota","volume":"140","author":"McFarlane","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0450","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tim.2022.01.007_bb0455","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0460","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of covid-19 and influenza highlights the role of type i interferons in development of severe covid-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0465","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 \u2013 interim WHO Solidarity Trial results","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tim.2022.01.007_bb0470","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.tim.2022.01.007_bb0475","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-2600(20)30566-X","article-title":"Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial","volume":"9","author":"Feld","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.tim.2022.01.007_bb0480","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Monk","year":"2021","journal-title":"Artic. Lancet Respir. Med."},{"key":"10.1016\/j.tim.2022.01.007_bb0485","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.cmi.2021.05.020","article-title":"An open-label randomized controlled trial of the effect of lopinavir\/ritonavir, lopinavir\/ritonavir plus IFN-\u03b2-1a and hydroxychloroquine in hospitalized patients with COVID-19","volume":"27","author":"Ader","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.tim.2022.01.007_bb0490","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type III Interferons \u2013 induction, signaling, evasion, and application to combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2022.01.007_bb0495","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2020.07.005","article-title":"Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients","volume":"28","author":"Wang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2022.01.007_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.750279","article-title":"Age-related expression of IFN-\u03bb1 versus IFN-I and beta-defensins in the nasopharynx of SARS-CoV-2-infected individuals","volume":"12","author":"Gilbert","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0510","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","article-title":"The interferon landscape along the respiratory tract impacts the severity of COVID-19","volume":"184","author":"Sposito","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tim.2022.01.007_bb0515","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/vim.2020.0076","article-title":"Protective potentials of type III interferons in COVID-19 patients: lessons from differential properties of type I- and III interferons","volume":"34","author":"Jafarzadeh","year":"2021","journal-title":"Viral Immunol."},{"key":"10.1016\/j.tim.2022.01.007_bb0520","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","article-title":"Linking the human gut microbiome to inflammatory cytokine production capacity","volume":"167","author":"Schirmer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tim.2022.01.007_bb0525","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tim.2022.01.007_bb0530","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.immuni.2015.11.012","article-title":"Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures","volume":"43","author":"Nakaya","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2022.01.007_bb0535","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tim.2022.01.007_bb0540","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","article-title":"Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans","volume":"178","author":"Hagan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tim.2022.01.007_bb0545","doi-asserted-by":"crossref","first-page":"23782","DOI":"10.1073\/pnas.2010834117","article-title":"Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids","volume":"117","author":"Lin","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2022.01.007_bb0550","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00250-18","article-title":"Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells","volume":"92","author":"Holly","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2022.01.007_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1008057","article-title":"Astrovirus replication in human intestinal enteroids reveals multi-cellular tropism and an intricate host innate immune landscape","volume":"15","author":"Kolawole","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2022.01.007_bb0560","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1073\/pnas.1617363114","article-title":"Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner","volume":"114","author":"Drummond","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2022.01.007_bb0565","doi-asserted-by":"crossref","first-page":"E570","DOI":"10.1073\/pnas.1615422114","article-title":"A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection","volume":"114","author":"Saxena","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2022.01.007_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107863","article-title":"Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells. ll Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells","volume":"32","author":"Stanifer","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tim.2022.01.007_bb0575","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s12276-020-0386-0","article-title":"Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches","volume":"52","author":"Min","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tim.2022.01.007_bb0580","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jcmgh.2017.12.001","article-title":"Engineered human gastrointestinal cultures to study the microbiome and infectious diseases","volume":"5","author":"Blutt","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X22000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X22000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:47:18Z","timestamp":1760813238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X22000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":115,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0966842X22000075"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2022.01.007","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota regulation of viral infections through interferon signaling","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2022.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}